Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $203,299 - $265,150
-5,000 Reduced 58.82%
3,500 $163,000
Q2 2022

Aug 12, 2022

BUY
$40.85 - $77.67 $204,250 - $388,350
5,000 Added 142.86%
8,500 $373,000
Q1 2022

May 13, 2022

SELL
$59.95 - $92.06 $809,325 - $1.24 Million
-13,500 Reduced 79.41%
3,500 $253,000
Q4 2021

Feb 11, 2022

SELL
$81.07 - $121.29 $867,448 - $1.3 Million
-10,700 Reduced 38.63%
17,000 $1.38 Million
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $877,114 - $1.43 Million
-8,600 Reduced 23.69%
27,700 $3.22 Million
Q2 2021

Aug 13, 2021

BUY
$141.6 - $179.06 $3.57 Million - $4.51 Million
25,200 Added 227.03%
36,300 $6.02 Million
Q1 2021

May 14, 2021

SELL
$132.81 - $182.18 $4.97 Million - $6.81 Million
-37,400 Reduced 77.11%
11,100 $1.55 Million
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $1.75 Million - $2.34 Million
-12,700 Reduced 20.75%
48,500 $8.4 Million
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $3.72 Million - $4.74 Million
32,600 Added 113.99%
61,200 $8.53 Million
Q2 2020

Aug 14, 2020

BUY
$89.45 - $129.85 $1.41 Million - $2.05 Million
15,800 Added 123.44%
28,600 $3.42 Million
Q1 2020

May 14, 2020

SELL
$70.23 - $144.31 $716,346 - $1.47 Million
-10,200 Reduced 44.35%
12,800 $1.28 Million
Q4 2019

Feb 13, 2020

BUY
$76.41 - $117.54 $626,562 - $963,828
8,200 Added 55.41%
23,000 $2.7 Million
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $1.57 Million - $1.82 Million
-27,100 Reduced 64.68%
14,800 $959,000
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $1.06 Million - $1.87 Million
29,800 Added 246.28%
41,900 $2.62 Million
Q3 2018

Nov 13, 2018

BUY
$44.22 - $75.47 $535,062 - $913,187
12,100 New
12,100 $690,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $162M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.